VIATRIS INC.

VTRS

CIK 0001792044 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$3.70B
↑+5.0% +$176Mvs FY2024 (Q4)
Gross Profit
$1.15B
↓-5.5% -$67Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
25/100
  • Profitability
    0ROIC -7.0% (10% = solid, 20%+ = moat)
  • Liquidity
    44Current Ratio 1.38 (above 1.5 = solid)
  • Leverage
    58D/E 0.85 (under 0.5 = conservative)
  • Efficiency
    13Asset Turnover 0.36x (1.0+ = capital-efficient)
  • Growth
    33Revenue YoY +5.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 4.8% · trend -27.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project VTRS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -9.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$29.18
Total enterprise IV
$27.04B
Diluted shares
0.93B
Terminal PV
$19.06B (70% of total)
Year-5 FCF
$2.25B
YearProjected FCFDiscounted PV
+1$2.00B$1.81B
+2$2.06B$1.70B
+3$2.12B$1.59B
+4$2.18B$1.49B
+5$2.25B$1.39B
Terminal$30.69B$19.06B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$379M
investment in PP&E
Dividends paid (TTM)
cash returned to holders
Stock buybacks (TTM)
$503M
share count reduction
Stock-based comp (TTM)
$178M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$37.19B
everything owned
Total liabilities
$22.48B
everything owed
Stockholders' equity
$14.71B
shareholder claim
Net debt
$11.16B
LT debt minus cash

Recent performance · 32 quarters

Revenue↑+5.0% +$176M
$3.70B
Net Income↓-235.2% -$223M
$-128M
Free Cash Flow↑+80.9% +$277M
$619M
Operating Margin↓-1.3pts
4.8%

Drill down